^
BIOMARKER:

JAK2 mutation

i
Other names: JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2
Entrez ID:
JAK2 mutation
AML
ruxolitinib
Sensitive: C2 – Inclusion Criteria
JAK2 mutation
Leukemia
ruxolitinib
Sensitive: C2 – Inclusion Criteria
JAK2 mutation
AML
LY3009120
Sensitive: C3 – Early Trials